• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Inhaled corticosteroids and mortality in COPD: are we there yet?吸入性糖皮质激素与慢性阻塞性肺疾病的死亡率：我们做到了吗？
Thorax. 2006 Aug;61(8):735.
2
Inhaled fluticasone and salmeterol suppress eosinophilic airway inflammation in chronic obstructive pulmonary disease: relations with lung function and bronchodilator reversibility.吸入氟替卡松和沙美特罗可抑制慢性阻塞性肺疾病中的嗜酸性气道炎症：与肺功能及支气管扩张剂可逆性的关系
Lung. 2006 Jul-Aug;184(4):217-22. doi: 10.1007/s00408-005-2586-8.
3
The EFFECT trial: evaluating exacerbations, biomarkers, and safety outcomes with two dose levels of fluticasone propionate/formoterol in COPD.EFFECT试验：评估慢性阻塞性肺疾病中两种剂量的丙酸氟替卡松/福莫特罗对病情加重、生物标志物及安全性结果的影响
Int J Chron Obstruct Pulmon Dis. 2015 Nov 9;10:2431-8. doi: 10.2147/COPD.S93375. eCollection 2015.
4
The bioavailability and airway clearance of the steroid component of budesonide/formoterol and salmeterol/fluticasone after inhaled administration in patients with COPD and healthy subjects: a randomized controlled trial.布地奈德/福莫特罗和沙美特罗/氟替卡松吸入治疗 COPD 患者和健康受试者后，其类固醇成分的生物利用度和气道清除率：一项随机对照试验。
Respir Res. 2009 Oct 31;10(1):104. doi: 10.1186/1465-9921-10-104.
5
Comparison table: Inhaled corticosteroids for treatment of COPD.比较表：用于治疗慢性阻塞性肺疾病的吸入性糖皮质激素
Med Lett Drugs Ther. 2020 Sep 7;62(1606):e148-e149.
6
Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.吸入性糖皮质激素与长效β₂受体激动剂治疗慢性阻塞性肺疾病的比较
Cochrane Database Syst Rev. 2011 Oct 5(10):CD007033. doi: 10.1002/14651858.CD007033.pub2.
7
Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.吸入性糖皮质激素与长效β2受体激动剂治疗慢性阻塞性肺疾病的比较
Cochrane Database Syst Rev. 2011 Dec 7;2011(12):CD007033. doi: 10.1002/14651858.CD007033.pub3.
8
Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease.联合使用皮质类固醇和长效β2受体激动剂的单一吸入器与单独使用吸入性皮质类固醇治疗慢性阻塞性肺疾病的比较
Cochrane Database Syst Rev. 2013 Aug 30;2013(8):CD006826. doi: 10.1002/14651858.CD006826.pub2.
9
Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease.吸入性糖皮质激素与长效β2受体激动剂联合用药对比噻托溴铵治疗慢性阻塞性肺疾病
Cochrane Database Syst Rev. 2013 May 31;2013(5):CD007891. doi: 10.1002/14651858.CD007891.pub3.
10
Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.联合使用皮质类固醇和长效β2受体激动剂的单一吸入器与长效β2受体激动剂治疗慢性阻塞性肺疾病的比较
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD006829. doi: 10.1002/14651858.CD006829.pub2.

引用本文的文献

1
Inhaled corticosteroids and mortality in COPD.慢性阻塞性肺疾病中吸入性糖皮质激素与死亡率
Thorax. 2006 Oct;61(10):918.

本文引用的文献

1
Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease.吸入性糖皮质激素与慢性阻塞性肺疾病的死亡率
Thorax. 2005 Dec;60(12):992-7. doi: 10.1136/thx.2005.045385. Epub 2005 Oct 14.
2
The TORCH (towards a revolution in COPD health) survival study protocol.TORCH（迈向慢性阻塞性肺疾病健康革命）生存研究方案。
Eur Respir J. 2004 Aug;24(2):206-10. doi: 10.1183/09031936.04.00120603.
3
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper.慢性阻塞性肺疾病患者的诊断和治疗标准：美国胸科学会/欧洲呼吸学会立场文件摘要
Eur Respir J. 2004 Jun;23(6):932-46. doi: 10.1183/09031936.04.00014304.
4
Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care.慢性阻塞性肺疾病。成人慢性阻塞性肺疾病在初级和二级医疗保健中管理的国家临床指南。
Thorax. 2004 Feb;59 Suppl 1(Suppl 1):1-232.
5
Inhaled corticosteroids in chronic obstructive pulmonary disease and risk of death and hospitalization: time-dependent analysis.慢性阻塞性肺疾病中吸入性糖皮质激素与死亡和住院风险：时间依赖性分析
Am J Respir Crit Care Med. 2003 Dec 15;168(12):1488-94. doi: 10.1164/rccm.200301-019OC. Epub 2003 Oct 2.
6
C-reactive protein and incident coronary heart disease in the Atherosclerosis Risk In Communities (ARIC) study.社区动脉粥样硬化风险（ARIC）研究中的C反应蛋白与冠心病发病情况
Am Heart J. 2002 Aug;144(2):233-8. doi: 10.1067/mhj.2002.124054.
7
The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials.吸入性糖皮质激素对慢性阻塞性肺疾病的影响：随机安慰剂对照试验的系统评价
Am J Med. 2002 Jul;113(1):59-65. doi: 10.1016/s0002-9343(02)01143-9.

Inhaled corticosteroids and mortality in COPD: are we there yet?

作者信息

Stirling R

出版信息

Thorax. 2006 Aug;61(8):735.

PMID:16877693
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2104685/
Abstract
摘要